Johnson & Johnson Ltd’s Pat Smallcombe elected as new PAGB President

Published on: 23 September 2016


Pat Smallcombe, ‎Area Managing Director Northern Europe, Johnson & Johnson Ltd, has been elected as the new President of PAGB, the UK trade association for manufacturers of over-the-counter (OTC) medicines, self care medical devices and food supplements.

Mr Smallcombe has been a PAGB Vice President since 2014 and was elected President at the PAGB AGM on 23 September 2016. He takes over from Carlton Lawson of GSK who has been appointed Head of Global Categories at GlaxoSmithKline Consumer Healthcare.

Also at the AGM, Steve Troote, SVP Northern Europe and Australia/New Zealand at RB was re-elected Vice Chair and David Barnett, Area General Manager Northern Europe, GSK Consumer Healthcare was also elected Vice Chair.

John Smith, PAGB Chief Executive, said:

“I am looking forward to working closely with Pat Smallcombe as President. Pat brings with him a wealth of experience in the consumer healthcare industry, both in the UK and globally, which will be invaluable to the Board.

“In Pat, Steve and David, we have a strong team leading the PAGB Board and I am confident this will enable us to move the PAGB forward and deliver on our strategy to shape the consumer healthcare market.

“On behalf of the PAGB Board, I would like to congratulate Carlton Lawson on his new role at GSK and thank him for his contribution to PAGB.”

Pat Smallcombe said:

“I am delighted to be taking up the role of PAGB President at this time. With the NHS facing continuing financial pressures, we need, more than ever, to support and empower people to self care. I look forward to building on the work PAGB has done to further the self care agenda and promote a people-centric approach to regulatory decision making.”

Johnson & Johnson Ltd’s Pat Smallcombe elected as new PAGB President